CC BY-NC-ND 4.0 · Z Gastroenterol 2023; 61(09): 1207-1213
DOI: 10.1055/a-1976-9971
Originalarbeit

Validation of the German version of the Short Health Scale – a brief, valid and reliable instrument to assess health-related quality of life in German-speaking patients with inflammatory bowel diseases

Validierung der deutschen Version der Short Health Scale – ein kurzes und zuverlässiges Instrument zur Beurteilung der gesundheitsbezogenen Lebensqualität bei Patient:innen mit chronisch-entzündlichen Darmerkrankungen
Sina Demmer
1   Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, University Medical Centre Mannheim, Mannheim, Germany (Ringgold ID: RIN36642)
,
Nikolaus Kleindienst
2   Department of Psychosomatic Medicine and Psychotherapy, Medical Faculty Mannheim, Heidelberg University, Central Institute of Mental Health, Mannheim, Germany (Ringgold ID: RIN27188)
,
Henrik Hjortswang
3   Department of Health, Medicine, and Caring Sciences, Linköping University, Linkoping, Sweden (Ringgold ID: RIN4566)
,
Philipp Thomann
4   Center for Mental Health, Odenwald District Healthcare Centre, Odenwald District, Erbach, Germany (Ringgold ID: RIN505222)
,
Matthias Ebert
1   Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, University Medical Centre Mannheim, Mannheim, Germany (Ringgold ID: RIN36642)
,
Wolfgang Reindl
1   Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, University Medical Centre Mannheim, Mannheim, Germany (Ringgold ID: RIN36642)
,
Anne Thomann
1   Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, University Medical Centre Mannheim, Mannheim, Germany (Ringgold ID: RIN36642)
› Institutsangaben
Gefördert durch: Land Baden-Württemberg BW-ZDFP
Gefördert durch: Deutsche Forschungsgemeinschaft GRK 2350,GRK2727,RE 2706 ,TH2341

Abstract

Background Health-related quality of life (hrQoL) may be the most important patient-reported outcome for patients with chronic disorders. The Short Health Scale (SHS) is a brief four-item instrument to assess hrQoL in patients with bowel disorders. This study examined the validity, reliability and sensitivity of the German translation of the SHS in a cohort of outpatients with inflammatory bowel diseases (IBD).

Methods The study was preregistered in April 2021 (https://doi.org/10.17605/OSF.IO/S82D9). Outpatients with IBD (n=225) in different stages of disease activity (as determined by the Harvey–Bradshaw index or partial Mayo score) completed the German SHS and the short Inflammatory Bowel Disease Questionnaire (sIBDQ) as an established measure of hrQoL to examine the convergent validity. To assess reliability, a subset of patients (n=30) in remission completed the same questionnaires after 4–8 weeks. Sensitivity to change was established from questionnaires of patients with either decreased (n=15) or increased (n=16) disease activity after 3–6 months.

Results The internal consistency of the German SHS was high (Cronbach’s α=0.860). SHS total scores correlated strongly with sIBDQ scores (ρ=–0.760, p<0.001) and disease activity (ρ=0.590, p<0.001). Retest reliability was high (ρ=0.695, p<0.001). Sensitivity to change was statistically significant for patients with decreased (p=0.013) but not increased (p=0.134) disease activity.

Conclusion The German version of the SHS is a valid and reliable tool to measure hrQoL in persons with IBD.

Zusammenfassung

Einleitung Chronisch-entzündliche Darmerkrankungen (CED) können die Lebensqualität (QoL) der Betroffenen stark beeinträchtigen. Die Short Health Scale (SHS) ist ein aus 4 visuellen Analogskalen bestehender Fragebogen zur Beurteilung der QoL bei Personen mit Darmerkrankungen, der in Schweden entwickelt und in verschiedenen Sprachen validiert wurde. In dieser Studie wurde die deutsche Übersetzung der SHS validiert.

Methodik Die Studie wurde im April 2021 präregistriert (https://doi.org/10.17605/OSF.IO/S82D9). Ambulante PatientInnen mit CED (n=225) in verschiedenen Krankheitsstadien (definiert durch Harvey-Bradshaw-Index oder partiellen Mayo-Score) nahmen teil. Sie beantworteten die SHS und als etabliertes QoL-Instrument die Kurzform des Inflammatory Bowel Disease Questionnaire (sIBDQ). Zur Beurteilung der Reliabilität und Änderungssensitivität wurden Subgruppen (n=30 in Remission bzw. n=31 mit veränderter Krankheitsaktivität) nach 4–8 Wochen bzw. 3–6 Monaten erneut befragt.

Ergebnis Die interne Konsistenz der SHS war hoch mit einem Cronbachs α=0.860. SHS-Scores korrelierten stark mit dem sIBDQ (ρ=–0.760, p<0.001) und der Krankheitsaktivität (ρ=0.590; p<0.001). Die Retest-Reliabilität war hoch (ρ=0.695, p<0.001), während die Änderungssensitivität bei Pat. mit sinkender (p=0.013), aber nicht bei steigender (p=0.134) Krankheitsaktivität signifikant war.

Schlussfolgerung Die SHS ist ein kurzer und zuverlässiger Fragebogen zur Beurteilung der QoL bei Personen mit CED und kann lizenzfrei klinisch und wissenschaftlich eingesetzt werden.



Publikationsverlauf

Eingereicht: 26. April 2022

Angenommen nach Revision: 06. Oktober 2022

Artikel online veröffentlicht:
10. Januar 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Knowles SR, Keefer L, Wilding H. et al. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. Inflamm Bowel Dis 2018; 24: 966-976
  • 2 Knowles SR, Graff LA, Wilding H. et al. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. Inflamm Bowel Dis 2018; 24: 742-751
  • 3 Rosen MJ, Dhawan A, Saeed SA. Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr 2015; 169: 1053-1060
  • 4 Rogler G, Singh A, Kavanaugh A. et al. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology 2021; 161: 1118-1132
  • 5 Thomann AK, Knodler LL, Karthikeyan S. et al. The Interplay of Biopsychosocial Factors and Quality of Life in Inflammatory Bowel Diseases: A Network Analysis. Journal of Clinical Gastroenterology 2021;
  • 6 Kappelman MD, Long MD, Martin C. et al. Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2014; 12: 1315-1323 e1312
  • 7 Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Annals of Internal Medicine 1993; 118: 622-629
  • 8 Turner D, Ricciuto A, Lewis A. et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021; 160: 1570-1583
  • 9 Calviño-Suárez C, Ferreiro-Iglesias R, Bastón-Rey I. et al. Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment. Int J Environ Res Public Health 2021; 18
  • 10 Janke KH, Klump B, Steder-Neukamm U. et al. Validation of the German version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D). Psychother Psychosom Med Psychol 2006; 56: 291-298
  • 11 Rose M, Fliege H, Hildebrandt M. et al. Validation of the new German translation version of the “Short Inflammatory Bowel Disease Questionnaire” (SIBDQ). Z Gastroenterol 2000; 38: 277-286
  • 12 Stjernman H, Granno C, Jarnerot G. et al. Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn’s disease. Inflammatory Bowel Diseases 2008; 14: 47-52
  • 13 Hjortswang H, Jarnerot G, Curman B. et al. The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol 2006; 41: 1196-1203
  • 14 Park SK, Ko BM, Goong HJ. et al. Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease. World J Gastroenterol 2017; 23: 3530-3537
  • 15 McDermott E, Keegan D, Byrne K. et al. The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients. J Crohns Colitis 2013; 7: 616-621
  • 16 Jelsness-Jorgensen LP, Bernklev T, Moum B. Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale (SHS). Qual Life Res 2012; 21: 1671-1676
  • 17 Coenen S, Weyts E, Geens P. et al. Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel disease. Scand J Gastroenterol 2019; 54: 592-596
  • 18 Cortina J. What is Coefficient Alpha? An Examination of Theory and Applications. Journal of Applied Psychology 1993; 78: 98-104